Interventions | 2001 % (95% CI) N | 2006 % (95% CI) N | 2010 % (95% CI) N | 2012–2013 % (95% CI) N | 2015 % (95% CI) N | Changea | p£ |
---|---|---|---|---|---|---|---|
Nets | |||||||
Household ownership | n/a | 40.5 (37.3–42.7) 31,910 | 62.9 (60.3–65.4) 7883 | 70.6 (69.4–71.8) 47,829 | n/a | 30.1 | < 0.0001 |
ITNs | |||||||
Household ownership ≥1 | n/a | 49.4 (46.6–52.2) 11,109 | 87.2 (84.1–89.7) 1428 | 84.4 (83.1–85.6) 10,105 | 93.0 (91.8–94.1) 4240 | 43.6 | < 0.0001 |
Use (children < 5 yrs) | n/a | 26.4 (24.0–29.0) 11,640 | 72.6 (68.2–76.7) 1801 | 69.0 (67.2–70.7) 10,634 | 71.2 (68.9–69.6) 7880 | 44.8 | < 0.0001 |
Use (pregnant women) | n/a | 27.6 (23.4–32.2) 1677 | 73.2 (69.6–76.5) 1200 | 77.9 (74.4–81.0) 774 | 50.3 | < 0.0001 | |
Use (all persons) | n/a | 20.7 (18.9–22.5) 61,758 | 56.9 (53.8–59.9) 8721 | 60.5 (59.0–62.0) 55,836 | 63.9 (62.0–65.8) 37,755 | 43.2 | < 0.001 |
IPTp during last pregnancy | |||||||
2+ doses | n/a | 10.1 (8.6–12.0) 4989 | NA | 28.5 (26.3–30.9) 3965 | 37.8 (34.5–41.1) 3017 | 27.7 | < 0.0001 |
Recommended first-line malaria treatment | |||||||
92.4* (90.0–94.3) 1049 | 5.5b (3.6–8.3) 677 | 23.3c (15.8–32.9) 241 | 19.0c (13.4–26.3) 187 | 28.9c (23.0–35.8) 590 | 5.6 | 0.0171 |